Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Selective Laser Photocoagulation Of Communicating Vessels

Research Leaders

10 sponsors active, led by University of Wisconsin, Madison

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed3
Not Yet Recruiting1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (5)

Research Network

Common Treatments

  • Selective Laser Photocoagulation Of Communicating Vessels2
  • Substudy Only Maternalinfant Pharmacogenomic Assessment Postnatally1
  • Fetal Magnetocardiogram And Neonatal Electrocardiogram1
  • Doppler Ultrasound Of Fetal Renal Artery1
  • Verasonics Vantage 256 Ultrasound1

Active Sponsors

  • University of Wisconsin, Madison1
  • National Heart, Lung, and Blood Institute (NHLBI)1
  • Virginia Polytechnic Institute and State University1
  • Advancing a Healthier Wisconsin Endowment1
  • University of South Florida1

Top Investigators

Related Conditions

  • Birth Defect1
  • Congenital Heart Disease1
  • Fetal Death1
  • Brugada Syndrome1
  • Fetal Hydrops1

Activity Timeline